CD4/CD8 ratio is not predictive of multi-morbidity prevalence in HIV-infected patients but identify patients with higher CVD risk

BACKGROUND: CD4/CD8<0.8 is a surrogate marker of immune-activation/immunosenescence and independently predicts mortality in the HIV-infected patients due to non-AIDS related events. Most studies showed that patients on antiretroviral therapy (ART) often fail to normalize the CD4/CD8 ratio despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Menozzi, Marianna, Zona, Stefano, Santoro, Antonella, Carli, Federica, Stentarelli, Chiara, Mussini, Cristina, Guaraldi, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P177
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225275/
https://www.ncbi.nlm.nih.gov/pubmed/25397456
http://dx.doi.org/10.7448/IAS.17.4.19709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225275/
https://www.ncbi.nlm.nih.gov/pubmed/25397456
http://dx.doi.org/10.7448/IAS.17.4.19709

Ejemplares similares